Get started Log in

BOT — Botanix Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Market Cap
AU$32.81m
Enterprise Value
AU$8.12m
Revenue
AU$33.80m

Botanix Pharmaceuticals hits one-week low on discounted capital raise
21/07/2023 02:59
Brief: Botanix Pharmaceuticals Says Received Commitments For A$12.5 Million Placement
21/07/2023 02:20
Brief: Botanix Pharmaceuticals Seeks Trading
19/07/2023 24:38
Brief: Botanix Pharmaceuticals Raises A$10 Mln Via Institutional Placement
05/04/2023 01:12
Brief: Botanix Pharmaceuticals Says Planned Approval Date For Sofpironium Bromide Remains On Track For Sept
03/04/2023 02:19
Brief: Botanix Pharmaceuticals Seeks Trading Halt
03/04/2023 02:09
Brief: Botanix Pharmaceuticals Says HY Loss From Cont Ops After Tax Attributable A$4.6 Mln
28/02/2023 07:08
Brief: Botanix Pharmaceuticals Seeks Trading Halt
14/02/2023 24:28
Brief: Botanix Pharmaceuticals Got Confirmation Sofpironium Bromide NDA Is Formally Under Review
08/12/2022 01:25
Brief: Botanix Pharmaceuticals Says It Secured A Commitment Of A$5.0 Million
31/10/2022 01:35
Brief: Botanix Pharmaceuticals Seeks Trading Halt
26/10/2022 23:45
Brief: Botanix Pharmaceuticals Seeks Trading Halt Pending Announcement In Relation To Clinical Study Results
11/10/2022 23:52
Botanix Pharmaceuticals jumps on submitting New Drug Application to US FDA
26/09/2022 03:49
Brief: Botanix Pharmaceuticals Announces Submission Of FDA New Drug Application For Sofpironium Bromide
26/09/2022 02:28
Australia-based Botanix Pharmaceuticals falls on discounted placement
02/09/2022 02:22
Brief: Botanix Pharmaceuticals Received Firm Commitments To Raise Up To A$7.5 Million
02/09/2022 24:28
Brief: Botanix Pharmaceuticals Posts FY Loss After Income Tax A$13.3 Million
31/08/2022 02:32
Brief: Botanix Pharmaceuticals Seeks Trading Halt
31/08/2022 24:33
Brief: Brickell Biotech Reports Q2 2022 Results
11/08/2022 22:33
ASX-listed Botanix Pharmaceuticals soars on buying rights to dermatology drug
04/05/2022 04:46